March 05, 2026. 3 articles reviewed below the CED clinical relevance threshold of 40. Listed in descending order of score.
High Schools Are Losing the Struggle to Block Pot—Even During Class – WSJ
# Clinical Summary Cannabis use among high school students appears to be increasing in jurisdictions with legalization, driven by greater accessibility and shifting social norms that normalize the drug. Schools are reporting difficulty enforcing policies against in-school cannabis consumption, with students using the substance during class periods and in school facilities. The normalization of cannabis use in legalized states may be contributing to reduced perception of risk among adolescents, a population particularly vulnerable to cannabis’s neurodevelopmental effects during critical periods of brain maturation. This trend has implications for youth mental health screening and counseling protocols in clinical settings serving this age group. Despite representing a public health rather than direct clinical concern, this article provides contextual understanding of the social and environmental factors influencing adolescent substance use patterns that clinicians may encounter when evaluating teenagers for behavioral, cognitive, or psychiatric symptoms.
Read more →Marijuana tax payouts dip in Michigan amid sales slump | WANE 15
Michigan’s cannabis tax revenue has declined, reflecting a broader sales slump in the state’s recreational marijuana market. The decrease in tax payouts indicates reduced consumer purchasing activity, which may signal market saturation, increased competition from illicit sources, or shifting consumer preferences. Revenue fluctuations in legal cannabis markets can provide epidemiologic insights into patterns of cannabis use and market dynamics across different regions. Understanding state-level market performance helps contextualize the economic viability of regulated cannabis systems and their ability to fund public health initiatives. This article may still merit review as declining legal market revenues often correlate with increased illicit market activity, which has implications for product safety, potency oversight, and public health surveillance.
Read more →Buy Recreational Marijuana Products in Columbus, OH | Bloom
This appears to be a commercial webpage for a marijuana dispensary in Columbus, Ohio, rather than a peer-reviewed clinical article. The content primarily functions as an age-verification landing page for recreational cannabis sales, with no substantive medical information, research data, or clinical guidance presented. The brief summary does not contain dosing information, cannabinoid profiles, adverse effect data, or evidence-based therapeutic applications that would be relevant to clinical practice. Medical professionals should be aware that such commercial dispensary websites typically do not meet standards for clinical evidence and should not be relied upon for patient education or treatment recommendations. However, understanding the regulatory framework and commercial availability of cannabis products in specific states may inform discussions with patients regarding legal access and product consistency requirements in their jurisdiction.
Read more →